Aim. To find the relationship between the size of embryoid bodies and the efficiency of pluripotent stem cells differentiation into cardiomyocytes. Methods. Transgenic murine iPSC line AT25 and D3 ESC line aPIG (clone 44) were differentiated into cardiomyocytes in AggreWell plates containing microwells which cause the pluripotent stem cells to aggregate into EBs of an appropriate size. Both cell lines were genetically modified and expressed IRES-flanked enhanced green fluorescent protein (eGFP) under the control of cardiac alpha myosin heavy chain promoter. We applied flow cytometry and fluorescence microscopy to test the efficiency of the differentiation processes. Results. The efficiency of differentiation of embryoid bodies formed from iPSC line AT25 and containing 250 and 1000 cells was found to be lower as compared to embryoid bodies formed of 500 and 750 cells. The number of eGFP+ cells derived from embryoid bodies of 500 cells was 8.5 times higher compared to embryoid bodies o f250 cells (2.86 ± 0.30 % cardiomyocytes per embryoid bod ies of 500 cells vs. only 0.34 % cardiomyocytes per embryoid bodies containing 250 cells); the difference was 4.7 times higher in comparison with embryoid bodies formed from 1000 cells. Conclusions. The size of em bryoid bodies can affect differentiation of pluripotent stem cells into cardiomyocytes. Among the embryoid bodies formed from 250 to 2000 cells per embryoid body, the highest percentage of eGFP+ cells was obtained from 500-cell embryoid bodies.
Introduction
The ability o f pluripotent stem cells (PSC) to prolif erate in vitro and differentiate into any cell o f three germ layers [1] , such as hepatocytes [2] , beta cells o f the pancreas [3] , cardiomyocytes [4] , osteoblasts [5] , endothelial cells [6] , neurons [7] and other makes them a target o f up-to-date research. Moreover, PSC can be used for disease modeling, drug toxicity screening or drug discovery, gene ther apy and cell replacement therapy [8] . One o f the main hurdles to overcome for achieving these goals is the determination o f controlled conditions re quired for the process o f differentiation.
It is known that the process o f differentiation is affected by various environmental stimuli such as m atrix components and cell-m atrix interactions, growth factors, cytokines, signaling molecules pro viding intercellular contacts [9, 10] . During em bryogenesis, the cell-cell interactions and cell posi tion are the key factors which direct the differentia tion. The same aspects influence the process in vitro [11] .
The Embryoid body (EB) formation is often used as a method for initiating differentiation. EBs are three-dimensional aggregates, representing the early stages o f embryo development. However, because the EB formation depends on various factors, it is much more disorganized in comparison with real embryo. Embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) form the aggregates covered with a layer o f visceral endoderm on the surface and an inner layer filled with primitive ecto derm cells, when the factors supporting PSC in un differentiated state are removed from the media. This arrangement is similar to the early stages o f em bryonic development, where the endoderm tissue, which is in direct contact with the mesoderm, stimu lates its development into cardiomyocytes [12] . It was proven that despite the differences in spatial or ganization most o f the cell types are formed inside EBs, including nerve cells, cardiomyocytes, hemato poietic cells and others. Due to the similarities be tween embryogenesis and EB formation, many o f the same growth factors are involved at the same stages [13, 14] .
In order to improve the efficiency o f differentia tion o f PSCs two main approaches are used. The first one is to supply cultivation medium with the factors involved in the process o f formation, maturation and proliferation o f the certain cell type. The second strategy is to adjust the physical parameters that in fluence the formation o f cell aggregates, such as the size and shape o f EBs [10, 8] . S. M. Dang et al [12] demonstrated that homogenization o f EB population can significantly improve the efficiency o f PSC dif ferentiation into cardiomyocytes. Little is known about the basis o f interconnection between EB size and shape and PSC direct differentiation. In order to reveal this mechanism, the profound molecular and cell research is required. Therefore it is important to find the relationship between the size o f embryoid bodies and the efficiency o f PSC differentiation into cardiomyocyte. by Rudolf Jaenisch and Alexander M eissner [15] . Transgenic murine D3 ESC line aPIG (clone 44) was described earlier [16] . Both cell lines were ge netically modified and express the puromycin resis tance gene N-acetyl-aminotransferase and the IRESflanked enhanced green fluorescent protein (eGFP) under the control o f cardiac alpha myosin heavy chain promoter (aMHC). The ability o f cardiomyo cytes to express eGFP under the control o f cardiaca-MHC promoter gave us the opportunity to apply flow cytometry and fluorescence microscopy to test the efficiency o f the differentiation processes [16] . These cells were maintained on irradiated mouse embryonic fibroblasts (MEF) in Dulbecco's minimal essential medium containing 15 % fetal bovine se rum (FBS), 1x non-essential amino acids (NEAA), 2 mM L-glutamine, 50 qM P-mercaptoethanol (P-ME) and 1000 U/ml leukemia inhibitory factor (LIF, ESGRO, Chemicon/Merck Millipore, Billerica, MA, USA). Unless otherwise specified, all cell cul ture reagents were obtained from Life Technologies (Carlsbad, CA, USA). Both stem cell lines iPSC and ESC were used in the experiments starting from the passage 5.
Materials and methods
AggreWellTM400 (Stem Cell Technologies) plates were used to start cardiomyocyte differentiation in differentiation medium. It consists o f Iscove's modi fied Dulbecco's medium containing 20 % FBS, 1x NEAA, 50 qM P-ME. These plates contain microw ells (400 qm in size) which cause the pluripotent stem cells (iPSC and ESC) to aggregate into EBs. The procedure was done accordantly to the m anu facturer's instructions from the AggreWell manual. Briefly 0.5 ml o f differentiation medium was placed into each well of an AggreWellTM400 plate, centri fuged at 2000g for 10 min in a swinging bucket rotor that was fitted with a plate holder to remove any small bubbles from the AggreWell plates. PSC were added to each well at concentrations o f 3x105 cells/ ml, 6x105 cells/ml, 9x105 cells/ml, 1.2x106 cells/ml and 2.4x106 cells/ml to make EBs with 250, 500, 750, 1000, and 2000 cells respectively. From each well o f the AggreWellTM400 plate we obtained 1200 EBs. The AggreWellTM400 plate was centri fuged at 200 g for 3 min to capture the cells in the wells. EBs were maintained under standard CO2 in cubator conditions (37 °C, 5 % CO2) for 48 h.
EBs were counted under a light microscope Axiovert 10 (ZEISS, Germany) after 2 days o f culti vation. Then they were transferred into Petry dishes with fresh differentiation medium and maintained on a shaker GFL 3006 (GFL, Braunschweig, Germany) under continuous horizontal agitation. Differentiation was continued without medium change until the 9th day and afterwards the medium was changed every 2-3 days.
Efficiency o f cardiac differentiation was analyzed by determining beating EBs and the fraction o f eGFP-positive cardiomyocytes on days 6, 9, 11, 13 and 15 o f differentiation by flow cytometry and fluo rescence microscopy. EBs were examined using Zeiss Axiovert 200M fluorescence microscope and analyzed with Zeiss Axiovision 4.5 software (Carl Zeiss, Jena, Germany). Single cell suspension was prepared for flow cytometry. Cells were analyzed by FACScan (BD Pharmingen). Cell debris was gated out and 10000 events were acquired for analysis. The presence o f dead cells was determined by propidium iodide staining (Sigma, Germany). Data anal ysis was performed using FSC Express 4 Flow Research Edition (De Novo Software, USA) soft ware.
The data on cell numbers are represented as mean ± standard deviation for 3 samples. Statistical sig nificance was determined using the Student t-test at P < 0.05.
Results and Discussion
Pluripotent stem cells, which include ESCs and iPSCs, have the ability to differentiate into the cells o f all three germ lineages including ectoderm, meso derm and endoderm. A lot o f differentiation proto cols start with the formation o f 3-dimensional ag gregates o f cells called embryoid bodies. The forma tion o f EBs heterogeneous in size and shape is a cause o f inefficient and uncontrolled differentiation. In order to get homogeneous population o f EBs, the AggreWell plates were used, each well of which (Fig.3, 4) .
It was found that the efficiency o f differentiation o f EBs with 250 and 1000 cells is lower compared with EBs o f 500 and 750 cells. So, on the 13-th day o f differentiation when the highest amount of car diomyocytes was obtained, the number o f eGFP+ Fig. 5) . According to our previous results [17] the murine ESC line had high ability to differentiate into cardio myocyte by a "hanging drop" method (EBs are at tached to the gelatin-covered Petry dishes) and by a mass culture method (EBs aggregate spontaneously by cultivation in nonadherent Petry dishes). During the first 2 days EBs in AgreWell plates form regular EBs similar to those obtained by the "hanging drop" method; starting from the third day they are culti vated in suspension likely to the mass culture m eth od. Therefore, we assume that the AgreWell method is linespecific and is insufficient to produce cardio myocytes from the applied ESC cell line. According to the outcome o f our work it is possi ble to improve the efficiency o f differentiation in cardio direction if the size o f EB changes. It is known that for the normal embryonic development o f the cardiovascular system different gradients o f signal ing molecules are required. For example, the factors secreted from neighboring lateral endoderm, such as BMP, stimulate cardiogenesis, whereas the canoni cal W nt signals from neighboring neuroectoderm inhibit cardiogenesis o f mesoderm [18] . Therefore, the ratio o f the endoderm and neuroectoderm can affect the processes o f differentiation. The size o f EBs, in turn, can affect the value formed by different cell layers.
EBs are the aggregates formed from PSC that are covered with endodermal cells on the surface, con taining nucleus formed from ectodermal cells in the middle o f it, and a layer o f mesodermal cells be tween two other layers. Modifying the EB size we change the amount o f endoderm on its surface. So we can assume that increasing the number o f endo derm cells we increase the number o f mesoderm cells. In turn mesoderm cells are transformed into cardiomyocytes by the factors secreted by endoderm cells. So we modulate cell position relatively to each other by changing the seeding density o f cells. Moreover EB size, which depends mainly on the ini tial amount o f PSC, forming EB, influences such pa rameters as diffusion o f soluble adhesion molecules and intercellular interactions. Therefore, it is possi ble that EBs, containing 500 cells have the most ap propriate ratio of the surface covered with endoderm cells to the surface o f mesoderm cells with which they can interact. A t the same time larger EBs be come unable to support diffusion o f cardiogenic fac tors, at the sufficient level for differentiation. Цель. Найти связь между размером эмбриоидных телец и эф фективностью дифференцировки плюрипотентных стволовых клеток в кардиомиоциты. Методы. Трансгенные клеточные линии индуцированных плюрипотешных клеток AT25 и эм бриональных стволовых клеток D3 aPIG44 дифференцирова ли в кардиомиоциты в AggreWell планшетах. Упомянутые планшеты содержат микролунки, которые дают возможность сформировать эмбриоидные тельца из плюрипотентных ство ловых клеток определенного заданного размера. Обе клеточ ные линии были генетически модифицированы и экспрессиро вали IRES-фланкированый зеленый флуоресцентный белок ^GFP), под контролем кардиоспецифического a-MHC промо-тера. Для проверки эффективности процессов дифференци-ровки были применены методы проточной цитометрии и флу оресцентной микроскопии. Результаты. Было установлено, что эффективность дифференцировки эмбриоидных телец по лученных из линии индуцированных плюрипотентных клеток AT25 размером 250 и 1000 клеток меньше по сравнению с эм бриональными тельцами сформированными из 500 и 750 кле ток. Количество eGFP + клеток, полученных из эмбриоидных телец размером 500 клеток была 8,5 раз больше чем по сравне нию с эмбриональными тельцами размером 250 клеток (что составляло 2,86 ± 0,30 % кардиомиоцитов для эмбриоидных телец размером 500 клеток, и только 0,34 % eGFP+ клеток для эмбриоидных телец размером 250 клеток). Выводы. Измене ние первоначального размера эмбриоидных телец влияет на эффективность дифференцировки плюрипотентных стволо вых клеток в кардиомиоциты. Среди эмбриоидных телец, об разованных в диапазоне от 250 до 2000 клеток, высокий про цент eGFP + клеток получали из эмбриоидных телец, образо ванных 500 клетками.
Conclusions
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